I invested in Braskem (BAK) due to the substantial growth forecast for the bioplastics market and the company's attractive pricing amidst strong momen...
Read
More
I invested in Braskem (BAK) due to the substantial growth forecast for the bioplastics market and the company's attractive pricing amidst strong momentum. Additionally, recent acquisition interest from Abu Dhabi's Adnoc provides a potential upside, making it a great opportunity for a long position.